These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31442032)

  • 1. Understanding Conditional Associations between ToxCast
    Mahmoud SY; Svensson F; Zoufir A; Módos D; Afzal AM; Bender A
    Chem Res Toxicol; 2020 Jan; 33(1):137-153. PubMed ID: 31442032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structure.
    Liu J; Mansouri K; Judson RS; Martin MT; Hong H; Chen M; Xu X; Thomas RS; Shah I
    Chem Res Toxicol; 2015 Apr; 28(4):738-51. PubMed ID: 25697799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space.
    Shah F; Greene N
    Chem Res Toxicol; 2014 Jan; 27(1):86-98. PubMed ID: 24328225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
    Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
    Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.
    Tolosa L; Jiménez N; Pérez G; Castell JV; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2018 Jan; 92(1):383-399. PubMed ID: 28762043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.
    Segovia-Zafra A; Villanueva-Paz M; Serras AS; Matilla-Cabello G; Bodoque-García A; Di Zeo-Sánchez DE; Niu H; Álvarez-Álvarez I; Sanz-Villanueva L; Godec S; Milisav I; Bagnaninchi P; Andrade RJ; Lucena MI; Fernández-Checa JC; Cubero FJ; Miranda JP; Nelson LJ
    J Hepatol; 2024 Oct; 81(4):630-640. PubMed ID: 38703829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the ToxCast Chemical-Assay Space Using the Comparative Toxicogenomics Database.
    Hu B; Gifford E; Wang H; Bailey W; Johnson T
    Chem Res Toxicol; 2015 Nov; 28(11):2210-23. PubMed ID: 26505644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high content screening assay to predict human drug-induced liver injury during drug discovery.
    Persson M; Løye AF; Mow T; Hornberg JJ
    J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Concentration-Dependent Toxicity Data and Toxicokinetics To Inform Hepatotoxicity Response Pathways.
    Russo DP; Aleksunes LM; Goyak K; Qian H; Zhu H
    Environ Sci Technol; 2023 Aug; 57(33):12291-12301. PubMed ID: 37566783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-Driven Read-Across of Chemical Hepatotoxicants Based on Chemical Structures and Biological Data.
    Zhao L; Russo DP; Wang W; Aleksunes LM; Zhu H
    Toxicol Sci; 2020 Apr; 174(2):178-188. PubMed ID: 32073637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing bioactivity-exposure profiles of fruit and vegetable extracts in the BioMAP profiling system.
    Wetmore BA; Clewell RA; Cholewa B; Parks B; Pendse SN; Black MB; Mansouri K; Haider S; Berg EL; Judson RS; Houck KA; Martin M; Clewell HJ; Andersen ME; Thomas RS; McMullen PD
    Toxicol In Vitro; 2019 Feb; 54():41-57. PubMed ID: 30218698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay.
    Beames T; Moreau M; Roberts LA; Mansouri K; Haider S; Smeltz M; Nicolas CI; Doheny D; Phillips MB; Yoon M; Becker RA; McMullen PD; Andersen ME; Clewell RA; Hartman JK
    Toxicol Appl Pharmacol; 2020 Jan; 387():114774. PubMed ID: 31783037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes.
    Tolosa L; Jiménez N; Pelechá M; Castell JV; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2019 Feb; 93(2):519-532. PubMed ID: 30426164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing.
    Wetmore BA; Wambaugh JF; Allen B; Ferguson SS; Sochaski MA; Setzer RW; Houck KA; Strope CL; Cantwell K; Judson RS; LeCluyse E; Clewell HJ; Thomas RS; Andersen ME
    Toxicol Sci; 2015 Nov; 148(1):121-36. PubMed ID: 26251325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro transcriptomic prediction of hepatotoxicity for early drug discovery.
    Cheng F; Theodorescu D; Schulman IG; Lee JK
    J Theor Biol; 2011 Dec; 290():27-36. PubMed ID: 21884709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data.
    Ye L; Ngan DK; Xu T; Liu Z; Zhao J; Sakamuru S; Zhang L; Zhao T; Xia M; Simeonov A; Huang R
    Toxicol Appl Pharmacol; 2022 Nov; 454():116250. PubMed ID: 36150479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most Influential Physicochemical and In Vitro Assay Descriptors for Hepatotoxicity and Nephrotoxicity Prediction.
    Rana P; Kogut S; Wen X; Akhlaghi F; Aleo MD
    Chem Res Toxicol; 2020 Jul; 33(7):1780-1790. PubMed ID: 32338883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using ToxCast to Explore Chemical Activities and Hazard Traits: A Case Study With Ortho-Phthalates.
    Pham N; Iyer S; Hackett E; Lock BH; Sandy M; Zeise L; Solomon G; Marty M
    Toxicol Sci; 2016 Jun; 151(2):286-301. PubMed ID: 26969370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of ToxCast Test Results with In Vivo and Other In Vitro Endpoints for Neuro, Endocrine, and Developmental Toxicities: A Case Study Using Endosulfan and Methidathion.
    Silva M; Pham N; Lewis C; Iyer S; Kwok E; Solomon G; Zeise L
    Birth Defects Res B Dev Reprod Toxicol; 2015 Apr; 104(2):71-89. PubMed ID: 26017137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.